2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Monday, September 23, 2019

1:45pm-3:15pm: Successful Treatment of Orthostatic Tremor using Perampanel

A. Wadhwa, S. Schaefer (New Haven, CT, USA)

Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3

1:45pm-3:15pm: Sudden alopecia secondary to levodopa treatment

N. Garcia Alvarado, N. López Ariztegui, MI. Morales Casado, JC. Segundo Rodríguez, C. Schoendorff Ortega, R. Almansa Castillo, JA. Perez Matos, A. ávila Fernández, C. Marsal Alonso (Toledo, Spain)

Neuropharmacology · Les Muses Terrace, Level 3

1:45pm-3:15pm: Super-urgent liver transplantation for a 62 year old with Wilson’s disease presenting with acute liver failure

S. Shribman, A. Shenoy, W. Griffiths, A. Gimson, T. Warner (London, United Kingdom)

Rare Genetic and Metabolic Diseases · Les Muses Terrace, Level 3

1:45pm-3:15pm: Supportive treatments for Ataxia, a Randomized Control Trial

MIA. Arain (Jamshoro, Pakistan)

Ataxia · Les Muses, Level 3

1:45pm-3:15pm: Survival estimates for Spinocerebellar Ataxia type 2 based on age at onset and CAG repeats length

L. Almaguer-Mederos, R. Aguilera-Rodríguez, Y. González-Zaldívar, D. Almaguer-Gotay, D. Cuello-Almarales, Y. Vázquez-Mojena, L. Velásquez-Pérez (Holguín, Cuba)

Ataxia · Les Muses, Level 3

1:45pm-3:15pm: Sustained mutant huntingtin lowering in the brain and cerebrospinal fluid of Huntington disease minipigs mediated by AAV5-miHTT gene therapy

A. Vallès-Sanchez, A. Stam, C. Brouwers, J. Klíma, B. Bohuslavová, R. Pintauro, M. Sogorb-Gonzalez, L. Paerels, V. Fodale, A. Bresciani, Z. Ellederová, B. Blits, J. Motlik, S. van Deventer, M. Evers, P. Konstantinova (Amsterdam, Netherlands)

Huntington’s Disease · Agora 3 West, Level 3

1:45pm-3:15pm: SWALLOWING VIDEOENDOSCOPY IN PATIENTS WITH PARKINSON’S DISEASE WITH DEEP BRAIN STIMULATION

T. Alves, N. Oliveira, G. Diaféria, M. Palumbo, MG. Ghilardi, E. Fonoff, M. Padovani (São Paulo, Brazil)

Other · Agora 2 West, Level 2

1:45pm-3:15pm: Switching entacapone ‘non-responders’ to open-label opicapone: change in absolute OFF-time following the 1-year extension BIPARK-I study

J. Ferreira, A. Lees, W. Poewe, O. Rascol, A. Santos, D. Magalhães, J. Rocha, P. Soares-da-Silva (Lisbon, Portugal)

Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3

1:45pm-3:15pm: Sydenham’s chorea: Clinical features and treatment outcome

S. Pandey, P. Rani (New Delhi, India)

Choreas (Non-Huntington’s Disease) · Les Muses, Level 3

1:45pm-3:15pm: Symptomatic treatment of hereditary spastic paraplegias with fampridine: a pilot study

M. Rosário, J. Ferreira, J. Ferro, L. Guedes (Lisbon, Portugal)

Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3